A Phase I Study of Temsirolimus, Topotecan, and Bortezomib in Patients with Advanced Malignancy.
Phase of Trial: Phase I
Latest Information Update: 12 Feb 2013
At a glance
- Drugs Bortezomib (Primary) ; Temsirolimus (Primary) ; Topotecan (Primary)
- Indications Cancer
- Focus Adverse reactions
- 01 Nov 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 29 Aug 2012 Status changed from recruiting to active, no longer recruiting as reported by M.D. Anderson Cancer Center.
- 14 Oct 2008 Integrated ClinicalTrials.gov record NCT00770731.